MR Molecular Imaging of Brain Cancer Metabolism Using Hyperpolarized 13C Magnetic Resonance Spectroscopy

Overview

Journal Top Magn Reson Imaging

Date 2016 Oct 18

PMID 27748711

Citations 14

Authors

Chloe Najac

Sabrina M Ronen

Affiliations

Soon will be listed here.

Abstract

Metabolic reprogramming is an important hallmark of cancer. Alterations in many metabolic pathways support the requirement for cellular building blocks that are essential for cancer cell proliferation. This metabolic reprogramming can be imaged using magnetic resonance spectroscopy (MRS). H MRS can inform on alterations in the steady-state levels of cellular metabolites, but the emergence of hyperpolarized C MRS has now also enabled imaging of metabolic fluxes in real-time, providing a new method for tumor detection and monitoring of therapeutic response. In the case of glioma, preclinical cell and animal studies have shown that the hyperpolarized C MRS metabolic imaging signature is specific to tumor type and can distinguish between mutant IDH1 glioma and primary glioblastoma. Here, we review these findings, first describing the main metabolic pathways that are altered in the different glioma subtypes, and then reporting on the use of hyperpolarized C MRS and MR spectroscopic imaging (MRSI) to probe these pathways. We show that the future translation of this hyperpolarized C MRS molecular metabolic imaging method to the clinic promises to improve the noninvasive detection, characterization, and response-monitoring of brain tumors resulting in improved patient diagnosis and clinical management.

Citing Articles

Inherited genetics of adult diffuse glioma and polygenic risk scores-a review.

Eckel-Passow J, Lachance D, Decker P, Kollmeyer T, Kosel M, Drucker K Neurooncol Pract. 2022; 9(4):259-270.

PMID: 35859544 PMC: 9290891. DOI: 10.1093/nop/npac017.

In Vivo C Magnetic Resonance Spectroscopy for Assessing Brain Biochemistry in Health and Disease.

Mandal P, Guha Roy R, Samkaria A, Maroon J, Arora Y Neurochem Res. 2022; 47(5):1183-1201.

PMID: 35089504 DOI: 10.1007/s11064-022-03538-8.

Therapeutic Response Assessment of High-Grade Gliomas During Early-Phase Drug Development in the Era of Molecular and Immunotherapies.

Ellingson B, Wen P, Cloughesy T Cancer J. 2021; 27(5):395-403.

PMID: 34570454 PMC: 8480435. DOI: 10.1097/PPO.0000000000000543.

Quantification of tumor microenvironment acidity in glioblastoma using principal component analysis of dynamic susceptibility contrast enhanced MR imaging.

Akbari H, Kazerooni A, Ware J, Mamourian E, Anderson H, Guiry S Sci Rep. 2021; 11(1):15011.

PMID: 34294864 PMC: 8298590. DOI: 10.1038/s41598-021-94560-3.

Denoising of hyperpolarized C MR images of the human brain using patch-based higher-order singular value decomposition.

Kim Y, Chen H, Autry A, Villanueva-Meyer J, Chang S, Li Y Magn Reson Med. 2021; 86(5):2497-2511.

PMID: 34173268 PMC: 8530853. DOI: 10.1002/mrm.28887.

References

Cabella C, Karlsson M, Canape C, Catanzaro G, Colombo Serra S, Miragoli L . In vivo and in vitro liver cancer metabolism observed with hyperpolarized [5-(13)C]glutamine. J Magn Reson. 2013; 232:45-52. DOI: 10.1016/j.jmr.2013.04.010. View

Esmaeili M, Hamans B, Navis A, van Horssen R, Bathen T, Gribbestad I . IDH1 R132H mutation generates a distinct phospholipid metabolite profile in glioma. Cancer Res. 2014; 74(17):4898-907. DOI: 10.1158/0008-5472.CAN-14-0008. View

Xing Y, Reed G, Pauly J, Kerr A, Larson P . Optimal variable flip angle schemes for dynamic acquisition of exchanging hyperpolarized substrates. J Magn Reson. 2013; 234:75-81. PMC: 3765634. DOI: 10.1016/j.jmr.2013.06.003. View

Bohndiek S, Kettunen M, Hu D, Kennedy B, Boren J, Gallagher F . Hyperpolarized [1-13C]-ascorbic and dehydroascorbic acid: vitamin C as a probe for imaging redox status in vivo. J Am Chem Soc. 2011; 133(30):11795-801. PMC: 3144679. DOI: 10.1021/ja2045925. View

Allouche-Arnon H, Gamliel A, Barzilay C, Nalbandian R, Gomori J, Karlsson M . A hyperpolarized choline molecular probe for monitoring acetylcholine synthesis. Contrast Media Mol Imaging. 2011; 6(3):139-47. DOI: 10.1002/cmmi.418. View

von Morze C, Larson P, Hu S, Keshari K, Wilson D, Ardenkjaer-Larsen J . Imaging of blood flow using hyperpolarized [(13)C]urea in preclinical cancer models. J Magn Reson Imaging. 2011; 33(3):692-7. PMC: 3566235. DOI: 10.1002/jmri.22484. View

Shi J, Sun B, Shi W, Zuo H, Cui D, Ni L . Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation. Tumour Biol. 2014; 36(2):655-62. DOI: 10.1007/s13277-014-2644-z. View

Warburg O . On the origin of cancer cells. Science. 1956; 123(3191):309-14. DOI: 10.1126/science.123.3191.309. View

Ohgaki H, Kleihues P . Genetic pathways to primary and secondary glioblastoma. Am J Pathol. 2007; 170(5):1445-53. PMC: 1854940. DOI: 10.2353/ajpath.2007.070011. View

10.

Horska A, Barker P . Imaging of brain tumors: MR spectroscopy and metabolic imaging. Neuroimaging Clin N Am. 2010; 20(3):293-310. PMC: 2927327. DOI: 10.1016/j.nic.2010.04.003. View

11.

Ichimura K, Pearson D, Kocialkowski S, Backlund L, Chan R, Jones D . IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas. Neuro Oncol. 2009; 11(4):341-7. PMC: 2743214. DOI: 10.1215/15228517-2009-025. View

12.

Gallagher F, Kettunen M, Hu D, Jensen P, In t Zandt R, Karlsson M . Production of hyperpolarized [1,4-13C2]malate from [1,4-13C2]fumarate is a marker of cell necrosis and treatment response in tumors. Proc Natl Acad Sci U S A. 2009; 106(47):19801-6. PMC: 2785247. DOI: 10.1073/pnas.0911447106. View

13.

Radoul M, Chaumeil M, Eriksson P, Wang A, Phillips J, Ronen S . MR Studies of Glioblastoma Models Treated with Dual PI3K/mTOR Inhibitor and Temozolomide:Metabolic Changes Are Associated with Enhanced Survival. Mol Cancer Ther. 2016; 15(5):1113-22. PMC: 4873419. DOI: 10.1158/1535-7163.MCT-15-0769. View

14.

Chaumeil M, Ozawa T, Park I, Scott K, James C, Nelson S . Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma. Neuroimage. 2011; 59(1):193-201. PMC: 3196046. DOI: 10.1016/j.neuroimage.2011.07.034. View

15.

Allouche-Arnon H, Wade T, Waldner L, Miller V, Gomori J, Katz-Brull R . In vivo magnetic resonance imaging of glucose - initial experience. Contrast Media Mol Imaging. 2012; 8(1):72-82. DOI: 10.1002/cmmi.1497. View

16.

Gatenby R, Gillies R . Why do cancers have high aerobic glycolysis?. Nat Rev Cancer. 2004; 4(11):891-9. DOI: 10.1038/nrc1478. View

17.

Ward C, Venkatesh H, Chaumeil M, Brandes A, VanCriekinge M, Dafni H . Noninvasive detection of target modulation following phosphatidylinositol 3-kinase inhibition using hyperpolarized 13C magnetic resonance spectroscopy. Cancer Res. 2010; 70(4):1296-305. PMC: 2822895. DOI: 10.1158/0008-5472.CAN-09-2251. View

18.

Gillies R, Morse D . In vivo magnetic resonance spectroscopy in cancer. Annu Rev Biomed Eng. 2005; 7:287-326. DOI: 10.1146/annurev.bioeng.7.060804.100411. View

19.

Glunde K, Bhujwalla Z, Ronen S . Choline metabolism in malignant transformation. Nat Rev Cancer. 2011; 11(12):835-48. PMC: 4337883. DOI: 10.1038/nrc3162. View

20.

Park I, von Morze C, Lupo J, Ardenkjaer-Larsen J, Kadambi A, Vigneron D . Investigating tumor perfusion by hyperpolarized C MRI with comparison to conventional gadolinium contrast-enhanced MRI and pathology in orthotopic human GBM xenografts. Magn Reson Med. 2016; 77(2):841-847. PMC: 4991955. DOI: 10.1002/mrm.26155. View